Long‐term outcomes after treatment of bare‐metal stent restenosis with paclitaxel‐coated balloon catheters or everolimus‐eluting stents: 3‐year follow‐up of the TIS clinical study | Zendy

Pleva Leos | Zendy; Kukla Pavel | Zendy; Zapletalova Jana | Zendy; Hlinomaz Ota | Zendy

Premium

Long‐term outcomes after treatment of bare‐metal stent restenosis with paclitaxel‐coated balloon catheters or everolimus‐eluting stents: 3‐year follow‐up of the TIS clinical study

Author(s) -

Pleva Leos,

Kukla Pavel,

Zapletalova Jana,

Hlinomaz Ota

Publication year - 2018

Publication title -

catheterization and cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.988

H-Index - 116

eISSN - 1522-726X

pISSN - 1522-1946

DOI - 10.1002/ccd.27688

Subject(s) - medicine , paclitaxel , restenosis , balloon , bare metal , everolimus , stent , bare metal stent , term (time) , angioplasty , surgery , drug eluting stent , chemotherapy , physics , quantum mechanics

The efficacy of paclitaxel-eluting balloon catheters (PEB) and drug-eluting stents for treatment of bare-metal stent restenosis (BMS-ISR) have been demonstrated in several studies with follow-up times of 9 to 12 months; however, the long-term outcomes of ISR treatment are less defined.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research